Novartis breast cancer drug Kisqali wins EU approval
Source: Pharma Times Novartis has announced the launch of its new breast cancer drug Kisqali in...
WHAT'S UP IN
Novartis
Novartis wins FDA approval for breast cancer drug aiming for Pfizer’s Ibrance
Source: Reuters Novartis on Monday won U.S. Food and Drug Administration approval for Kisqali to...
FDA okays new drug for type of advanced breast cancer
Author: Linda A. Johnson / Source: CTVNews The logo of Swiss pharmaceutical company...
Novartis’ HR+/HER2- advanced breast cancer trial gives superior progression-free survival
You are here: Home » News » Industry news » Novartis’ HR+/HER2- advanced...
